Needham Maintains Buy on C3.ai, Lowers Price Target to $122
Needham analyst Jack Andrews maintains C3.ai (NYSE:AI) with a Buy and lowers the price target from $146 to $122.
Piper Sandler Maintains Overweight on C3.ai, Lowers Price Target to $78
Piper Sandler analyst Arvind Ramnani maintains C3.ai (NYSE:AI) with a Overweight and lowers the price target from $98 to $78.
10 Stocks Moving In Wednesday’s After-Hours Session
Gainers
INmune Bio (NASDAQ: INMB) shares are trading higher after the company announced XPro has been found to decrease multiple species of Phospho Tau and improve neuroimaging biomarkers of myelination in patients with AD.
Moderna And DexCom Lead The Nasdaq-100
U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide.
Why C3.ai Stock Could Reverse Soon
C3.ai Inc. (NYSE: AI) shares were trading higher Wednesday, with the company scheduled to report second-quarter financial results after the closing bell.
The company is expected to report a quarterly loss at 28 cents per share with revenue of $51.16 million.
Cramer Weighs In On Academy Sports & Outdoors, Poshmark And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said that even after the big run, Academy Sports & Outdoors Inc (NASDAQ: ASO) is still inexpensive.
Understanding C3.ai’s Unusual Options Activity
On Tuesday, shares of C3.ai (NYSE:AI) saw unusual options activity. After the option alert, the stock price moved up to $51.35.
Analyzing C3.ai’s Unusual Options Activity
C3.ai (NYSE:AI) shares experienced unusual options activity on Friday. The stock price moved down to $48.82 following the option alert.
Return on Capital Employed Overview: C3.ai
Pulled from Benzinga Pro data C3.ai (NYSE:AI) reported Q4 sales of $52.28 million. Earnings fell to a loss of $23.91 million, resulting in a 29.24% decrease from last quarter.